Inocras

Inocras is a bioinformatics company founded in 2020 by physician-scientists, geneticists, and bioinformaticians to unlock the clinical potential of whole genome sequencing. Operating from San Diego with a CLIA-certified and CAP-accredited laboratory, Inocras has built a proprietary whole genome insight platform that analyzes a patient's complete DNA and delivers curated, clinically actionable findings for oncology and rare disease. The platform serves patients, providers, and researchers: patients receive easy-to-understand reports with genetic counseling support and clinical trial matching; providers gain automated bioinformatics analysis with expert advisory access; and researchers access end-to-end sequencing and interpretation services. Inocras raised $31 million in Series B-3 funding in 2026 to expand its platform into the U.S. market.